These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7562419)

  • 1. Kinetic evaluation of nonlinear drug elimination by a disposition decomposition analysis. Application to the analysis of the nonlinear elimination kinetics of erythropoietin in adult humans.
    Veng-Pedersen P; Widness JA; Pereira LM; Peters C; Schmidt RL; Lowe LS
    J Pharm Sci; 1995 Jun; 84(6):760-7. PubMed ID: 7562419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of nonlinear pharmacokinetics of erythropoietin in sheep and humans.
    Veng-Pedersen P; Widness JA; Pereira LM; Schmidt RL; Lowe LS
    Biopharm Drug Dispos; 1999 May; 20(4):217-23. PubMed ID: 10440797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Mechanism-Based Population Pharmacokinetics Model of Erythropoietin in Premature Infants and Healthy Adults Following Multiple Intravenous Doses.
    D'Cunha R; Widness JA; Yan X; Schmidt RL; Veng-Pedersen P; An G
    J Clin Pharmacol; 2019 Jun; 59(6):835-846. PubMed ID: 30618050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjects.
    Olsson-Gisleskog P; Jacqmin P; Perez-Ruixo JJ
    Clin Pharmacokinet; 2007; 46(2):159-73. PubMed ID: 17253886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tracer interaction method for nonlinear pharmacokinetics analysis: application to evaluation of nonlinear elimination.
    Veng-Pedersen P; Widness JA; Wang J; Schmidt RL
    J Pharmacokinet Biopharm; 1997 Oct; 25(5):569-93. PubMed ID: 9679223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A differential pharmacokinetic analysis of the erythropoietin receptor population in newborn and adult sheep.
    Veng-Pedersen P; Chapel S; Al-Huniti NH; Schmidt RL; Sedars EM; Hohl RJ; Widness JA
    J Pharmacol Exp Ther; 2003 Aug; 306(2):532-7. PubMed ID: 12750427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic differentiation of drug candidates using system analysis and physiological-based modelling. Comparison of C.E.R.A. and erythropoietin.
    Veng-Pedersen P; Freise KJ; Schmidt RL; Widness JA
    J Pharm Pharmacol; 2008 Oct; 60(10):1321-34. PubMed ID: 18812025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theorems and implications of a model independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. I. Derivations and theoretical analysis.
    Veng-Pedersen P
    J Pharmacokinet Biopharm; 1984 Dec; 12(6):627-48. PubMed ID: 6533297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-based model accounts for phlebotomy-induced changes in erythropoietin pharmacokinetics.
    Chapel SH; Veng-Pedersen P; Schmidt RL; Widness JA
    Exp Hematol; 2001 Apr; 29(4):425-31. PubMed ID: 11301182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. IV. Exact relationship between the terminal log-linear slope parameter beta and drug clearance.
    Veng-Pedersen P; Gillespie WR
    J Pharmacokinet Biopharm; 1987 Jun; 15(3):305-25. PubMed ID: 3668806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose Correction for a Michaelis-Menten Approximation of a Target-Mediated Drug Disposition Model with a Multiple Intravenous Dosing Regimens.
    Yan X; Ruixo JJP; Krzyzanski W
    AAPS J; 2020 Jan; 22(2):30. PubMed ID: 31950308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin production rate in phlebotomy-induced acute anemia.
    Al-Huniti NH; Widness JA; Schmidt RL; Veng-Pedersen P
    Biopharm Drug Dispos; 2004 Dec; 25(9):389-97. PubMed ID: 15529399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target-mediated disposition population pharmacokinetics model of erythropoietin in premature neonates following multiple intravenous and subcutaneous dosing regimens.
    D'Cunha R; Schmidt R; Widness JA; Mock DM; Yan X; Cress GA; Kuruvilla D; Veng-Pedersen P; An G
    Eur J Pharm Sci; 2019 Oct; 138():105013. PubMed ID: 31340188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug absorption evaluation in the presence of changes in clearance: an algorithm and computer program for deconvolution with exact clearance correction.
    Veng-Pedersen P
    Biopharm Drug Dispos; 1987; 8(2):185-203. PubMed ID: 3593898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic analysis of continuous erythropoietin receptor activator disposition in adult sheep using a target-mediated, physiologic recirculation model and a tracer interaction methodology.
    El-Komy MH; Widness JA; Veng-Pedersen P
    Drug Metab Dispos; 2011 Apr; 39(4):603-9. PubMed ID: 21209249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonlinear pharmacokinetics of visnagin in rats after intravenous bolus administration.
    Haug KG; Weber B; Hochhaus G; Butterweck V
    Eur J Pharm Sci; 2012 Jan; 45(1-2):79-89. PubMed ID: 22085634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semi-mechanistic Pharmacokinetic/Pharmacodynamic model of three pegylated rHuEPO and ior®EPOCIM in New Zealand rabbits.
    Reynaldo-Fernández G; Solozábal J; Amaro D; Fernández-Sánchez EM; Rodríguez-Vera L; Bermejo M; Mangas-Sanjuan V; Troconiz IF
    Eur J Pharm Sci; 2018 Jul; 120():123-132. PubMed ID: 29729414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. II. Clearance concepts applied to the evaluation of distribution kinetics.
    Gillespie WR; Veng-Pedersen P
    J Pharmacokinet Biopharm; 1985 Aug; 13(4):441-51. PubMed ID: 4087171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspects of theophylline clearance in children.
    Anderson BJ; Holford NH; Woollard GA
    Anaesth Intensive Care; 1997 Oct; 25(5):497-501. PubMed ID: 9352762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction for non-ideal tracer pharmacokinetic disposition by disposition decomposition analysis (DDA).
    Veng-Pedersen P; Hong SS; Widness JA; Schmidt RL
    Pharm Res; 1998 Sep; 15(9):1469-73. PubMed ID: 9755902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.